About Cypher Genomics
Cypher Genomics is a company based in San Diego (United States) founded in 2011 was acquired by Human Longevity in November 2015. It operates as a Professional Services. The company has 83 employees as of December 31, 2022. Cypher Genomics offers products and services including Mantis Genomic Coral Biomarker Array Chip and qPCR Assay. Cypher Genomics operates in a competitive market with competitors including GSK, DNAnexus, Avidity Biosciences, Sutro Biopharma and Antheia, among others.
- Headquarter San Diego, United States
- Employees 83 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Human Longevity, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Human Longevity
& 2 more
-
Employee Count
83
as on Dec 31, 2022
-
Acquired by
Human Longevity
(Nov 30, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cypher Genomics
Cypher Genomics offers a comprehensive portfolio of products and services, including Mantis Genomic Coral Biomarker Array Chip and qPCR Assay.
Used for detecting biomarkers in genomic research assays.
Employed for precise quantification of genetic material samples.
People of Cypher Genomics
Unlock access to complete
Funding Insights of Cypher Genomics
Investors in Cypher Genomics
Cypher Genomics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Human Longevity, Three Leaf Ventures and EvoNexus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage centric sector-agnostic venture capital firm funding companies in the US
|
Locked | Locked | Locked | |
|
12-18 month incubation programs are provided for startups in California.
|
Locked | Locked | Locked | |
|
Genomics data and cell therapy-based diagnostic and therapeutic solutions
|
Locked | Locked | Locked |
Investor details for Cypher Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cypher Genomics
Investment portfolio details for Cypher Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cypher Genomics
Detailed financials for Cypher Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cypher Genomics Comparisons
Peer comparison for Cypher Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cypher Genomics
Cypher Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, DNAnexus, Avidity Biosciences, Sutro Biopharma and Antheia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
Detailed competitors of Cypher Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cypher Genomics
Complete news archive for Cypher Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cypher Genomics
Cypher Genomics was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Cypher Genomics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
As of Dec 31, 2022, the latest employee count at Cypher Genomics is 83.
Cypher Genomics is involved in the development of genomic diagnostic tools and assays. The company focuses on solutions like the Mantis Genomic Coral Biomarker Array Chip and qPCR assays, targeting the biotechnology sector. Its offerings are utilized in research for detecting biomarkers, proteins, and molecules associated with various conditions. The company also provides resources and references for lab reagents and antibodies through its platform.
Cypher Genomics's top competitors include DNAnexus, Sutro Biopharma and Synthego.
Cypher Genomics offers Mantis Genomic Coral Biomarker Array Chip and qPCR Assay.
Cypher Genomics has 3 investors. Key investors include Human Longevity, Three Leaf Ventures, and EvoNexus.